> top > docs > PMC:7441788 > spans > 1191-1822 > annotations

PMC:7441788 / 1191-1822 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T13 89-97 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 184-192 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 299-307 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T16 382-390 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 537-545 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T18 557-604 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T19 557-590 Disease denotes severe acute respiratory syndrome http://purl.obolibrary.org/obo/MONDO_0005091
T20 606-614 Disease denotes SARS-CoV http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T6 25-26 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T14 27-36 Chemical denotes macrolide http://purl.obolibrary.org/obo/CHEBI_25106
T15 161-163 Chemical denotes CQ http://purl.obolibrary.org/obo/CHEBI_3638
T16 275-277 Chemical denotes CQ http://purl.obolibrary.org/obo/CHEBI_3638
T17 357-368 Chemical denotes application http://purl.obolibrary.org/obo/CHEBI_33232
T18 372-374 Chemical denotes CQ http://purl.obolibrary.org/obo/CHEBI_3638

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T11 27-36 Chemical denotes macrolide http://purl.obolibrary.org/obo/CHEBI_25106
T12 161-163 Chemical denotes CQ http://purl.obolibrary.org/obo/CHEBI_3638
T13 275-277 Chemical denotes CQ http://purl.obolibrary.org/obo/CHEBI_3638
T14 372-374 Chemical denotes CQ http://purl.obolibrary.org/obo/CHEBI_3638

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T11 89-97 Species denotes COVID-19 NCBItxid:2697049
T12 184-192 Species denotes COVID-19 NCBItxid:2697049
T13 299-307 Species denotes COVID-19 NCBItxid:2697049
T14 382-390 Species denotes COVID-19 NCBItxid:2697049
T15 537-545 Species denotes COVID-19 NCBItxid:2697049
T16 557-604 Species denotes severe acute respiratory syndrome coronavirus 2 NCBItxid:2697049
T17 606-616 Species denotes SARS-CoV-2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T15 99-202 Sentence denotes Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients.
T16 203-494 Sentence denotes Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies.
T17 496-498 Sentence denotes 1.
T18 500-512 Sentence denotes Introduction

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
105 557-604 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
106 606-616 Species denotes SARS-CoV-2 Tax:2697049
120 537-545 Disease denotes COVID-19 MESH:C000657245
46 75-83 Species denotes patients Tax:9606
47 193-201 Species denotes patients Tax:9606
56 27-36 Chemical denotes macrolide MESH:D018942
57 161-163 Chemical denotes CQ MESH:D002738
58 164-167 Chemical denotes HCQ MESH:D006886
59 275-277 Chemical denotes CQ MESH:D002738
60 278-281 Chemical denotes HCQ MESH:D006886
61 372-374 Chemical denotes CQ MESH:D002738
62 375-378 Chemical denotes HCQ MESH:D006886
70 89-97 Disease denotes COVID-19 MESH:C000657245
71 184-192 Disease denotes COVID-19 MESH:C000657245
72 299-307 Disease denotes COVID-19 MESH:C000657245
73 382-390 Disease denotes COVID-19 MESH:C000657245

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T5 525-532 http://purl.obolibrary.org/obo/OGMS_0000031 denotes disease

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T11 89-97 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T12 184-192 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T13 299-307 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T14 382-390 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T15 513-535 Disease denotes Coronavirus disease-19 http://purl.obolibrary.org/obo/MONDO_0100096
T16 537-545 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T17 557-604 Disease denotes severe acute respiratory syndrome coronavirus 2 http://purl.obolibrary.org/obo/MONDO_0100096
T18 606-616 Disease denotes SARS-CoV-2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sample-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 126-147 Phenotype denotes prolonged QT interval http://purl.obolibrary.org/obo/HP_0001657

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
46 75-83 Species denotes patients Tax:9606
47 193-201 Species denotes patients Tax:9606
56 27-36 Chemical denotes macrolide MESH:D018942
57 161-163 Chemical denotes CQ MESH:D002738
58 164-167 Chemical denotes HCQ MESH:D006886
59 275-277 Chemical denotes CQ MESH:D002738
60 278-281 Chemical denotes HCQ MESH:D006886
61 372-374 Chemical denotes CQ MESH:D002738
62 375-378 Chemical denotes HCQ MESH:D006886
70 89-97 Disease denotes COVID-19 MESH:C000657245
71 184-192 Disease denotes COVID-19 MESH:C000657245
72 299-307 Disease denotes COVID-19 MESH:C000657245
73 382-390 Disease denotes COVID-19 MESH:C000657245
105 557-604 Species denotes severe acute respiratory syndrome coronavirus 2 Tax:2697049
106 606-616 Species denotes SARS-CoV-2 Tax:2697049
119 513-535 Disease denotes Coronavirus disease-19 MESH:C000657245
120 537-545 Disease denotes COVID-19 MESH:C000657245

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T15 99-202 Sentence denotes Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients.
T16 203-494 Sentence denotes Therefore, current data are not sufficient enough to support the use of CQ/HCQ as therapies for COVID-19 and increasing caution should be taken about the application of CQ/HCQ in COVID-19 before conclusive findings are obtained by well-designed, multi-center, randomized, controlled studies.
T17 496-498 Sentence denotes 1.
T18 500-512 Sentence denotes Introduction

LitCovid-PD-HP

Id Subject Object Predicate Lexical cue hp_id
T1 126-147 Phenotype denotes prolonged QT interval http://purl.obolibrary.org/obo/HP_0001657